esophageal carcinoma
Showing 1 - 25 of 43
Atrial Fibrillation, Esophageal Carcinoma Trial in Portland (Amiodarone Hydrochloride, Saline)
Not yet recruiting
- Atrial Fibrillation
- Esophageal Carcinoma
- Amiodarone Hydrochloride
- Saline
-
Portland, OregonOHSU Knight Cancer Institute
Sep 28, 2023
Esophageal Carcinoma Trial in Nanjing (Nimotuzumab, Tigio, Concurrent radiation therapy)
Enrolling by invitation
- Esophageal Carcinoma
- Nimotuzumab
- +2 more
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023
Esophageal Carcinoma Trial in Shijiazhuang (toripalimab)
Recruiting
- Esophageal Carcinoma
-
Shijiazhuang, Hebei, ChinaFourth Hospital of Hebei Medical University
Aug 20, 2023
Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)
Not yet recruiting
- Esophageal Carcinoma
- Neoadjuvant Therapy
- Toripalimab
- +3 more
- (no location specified)
Aug 16, 2023
Minimally Residual of Esophageal Cancer 001
Recruiting
- Esophageal Carcinoma
- Minimal Residual Disease
-
Shijiazhuang, Hebei, ChinaFourth Hospital of Hebei Medical University
Jul 17, 2023
Esophageal Carcinoma Trial (Immune Checkpoint Inhibitors)
Not yet recruiting
- Esophageal Carcinoma
- Immune Checkpoint Inhibitors
- (no location specified)
Jul 6, 2023
Clear Cell Renal Cell Carcinoma, Cervical Carcinoma, Esophageal Carcinoma Trial in Nashville (CTX131)
Recruiting
- Clear Cell Renal Cell Carcinoma
- +4 more
- CTX131
-
Nashville, TennesseeResearch Site 1
Mar 21, 2023
Nivolumab in Treatment of Early Stage Esophageal or
Not yet recruiting
- Esophageal Carcinoma
- Gastroesophageal Junction Carcinoma
-
Louisville, Kentucky
- +2 more
Mar 21, 2023
Esophageal Carcinoma, Neoadjuvant Immunotherapy Trial in Beijing (PD-1 blockade, Albumin paclitaxel, Carboplatin/Nedaplatin)
Recruiting
- Esophageal Carcinoma
- Neoadjuvant Immunotherapy
- PD-1 blockade
- +2 more
-
Beijing, Beijing, ChinaQin li
Mar 8, 2023
Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,
Recruiting
- Breast Carcinoma
- +10 more
- Computed Tomography
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Nov 29, 2022
Caregiver, Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial in Houston (Educational Intervention,
Recruiting
- Esophageal Carcinoma
- +16 more
- Educational Intervention
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 11, 2022
Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab)
Completed
- Esophageal Carcinoma
- Esophagogastric Junction Carcinoma
- pembrolizumab
- (no location specified)
Aug 18, 2022
ResiduAl Cancer With Liquid Biopsy Evaluation
Recruiting
- Bladder Carcinoma
- +14 more
- Guardant Reveal
-
Redwood City, CaliforniaRedwood City
Sep 7, 2022
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Esophageal Carcinoma Trial in Rochester (mFOLFOX6, Chemoradiation)
Active, not recruiting
- Esophageal Carcinoma
- mFOLFOX6
- Chemoradiation
-
Rochester, New YorkUniversity of Rochester
Aug 17, 2022
Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial in China (pembrolizumab, paclitaxel, docetaxel)
Completed
- Esophageal Carcinoma
- Esophagogastric Junction Carcinoma
- pembrolizumab
- +3 more
-
Hefei, Anhui, China
- +22 more
Aug 16, 2022
Esophageal Carcinoma Trial in Tianjin (camrelizumab)
Recruiting
- Esophageal Carcinoma
-
Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Jul 25, 2022
Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab, paclitaxel, docetaxel)
Completed
- Esophageal Carcinoma
- Esophagogastric Junction Carcinoma
- pembrolizumab
- +3 more
- (no location specified)
May 5, 2022
Appendix Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Seattle (Acupuncture Therapy, Acupressure Therapy, Oral
Recruiting
- Appendix Carcinoma
- +12 more
- Acupuncture Therapy
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Apr 11, 2022
Esophageal Carcinoma, Neoadjuvant Chemoradiotherapy, Surgery Trial in Hangzhou (Higher dose (50.4Gy/28F) of neoadjuvant
Recruiting
- Esophageal Carcinoma
- +2 more
- Higher dose (50.4Gy/28F) of neoadjuvant chemoradiation
- Lower dose (41.4Gy/23F) of neoadjuvant chemoradiation
-
Hangzhou, Zhejiang, China
- +1 more
Mar 12, 2022
Yoga Program for Improving Quality of Life in Couples Coping
Recruiting
- Esophageal Carcinoma
- +3 more
- Best Practice
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Apr 26, 2021
Esophageal Cancer, Esophageal Carcinoma, Postoperative Complications Trial in L'Hospitalet De Llobregat (Esophagectomy)
Recruiting
- Esophageal Cancer
- +2 more
- Esophagectomy
-
L'Hospitalet De Llobregat, Barcelona, SpainHospital Universitari de Bellvitge
Nov 25, 2020
Acute and Late Normal Tissue in Patients Treated With Proton
Recruiting
- Breast Carcinoma
- +8 more
- Quality-of-Life Assessment
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Nov 11, 2020
Bronchial Carcinoma, Esophageal Carcinoma, Tumor of the Brain Trial in Tübingen (Fitness tracker based activity training for Arm
Recruiting
- Bronchial Carcinoma
- +6 more
- Fitness tracker based activity training for Arm A and B. Booklet "physical training, exercise and cancer" and an introduction about physical activity during cancer therapy for Arm A, B, C
-
Tübingen, Baden-Württemberg, GermanyUniversity Hospital Tübingen
Aug 13, 2020